Updated: November 2026
Today, all major hospitals in Israel offer CAR-T therapy that has been approved by the FDA. However, the high cost of American-made CAR-T therapies, which can reach up to $500,000, has led Israeli hospitals to develop their own CAR-T treatments to make them more accessible to patients.
The prices of home-grown (in-house) CAR-T therapies are significantly lower.
Currently, a few hospitals in Israel provide the treatment. Among them, Sheba Hospital, Ichilov Hospital, and Hadassah Hospital offer their own in-house CAR-T therapies, approved by the Helsinki Committee and the Israeli Ministry of Health. The treatment is highly cost-effective. Contact us for detailed pricing information.
At this time, CAR-T therapy is used to treat certain types of blood cancer, including Acute Lymphocytic Leukemia (ALL), Non-Hodgkin Lymphoma (NHL), Leukemia (ALL) in children, Multiple Myeloma, and Acute Myelogenous Leukemia (AML).
Which hospital in Israel is right for your CAR-T treatment?
Sheba and Hadassah are among the Israeli hospitals offering CAR-T therapy. The appropriate option depends on your diagnosis, previous treatments, medical condition and the programs currently accepting patients.
Let us help you clarify your options
We have accompanied dozens of CAR-T patients in Israel. We can coordinate an initial medical review and help you obtain relevant information about hospital options, eligibility, timing and costs.
Time is precious—let us help you move your research forward.
Contact us with a brief description of your case. Our coordination and support come at no additional fee.
Testimonial by a CAR-T patient at Hadassah hospital
My Husband and I engaged with Tanya Preminger from IHA to travel from New Zealand to Israel for undertaking Car T treatment. During the preparation stage Tanya was very professional in her approach and extremely responsive to our many emails. During our 8 week stay in Israel Tanya was incredibly supportive on both a practical and social level. Tanya was an effective communicator with ourselves and the Hadassah hospital staff, always accountable and flexible with our needs. We would highly recommend Tanya as a representative for other clients who may be considering various treatments in Israel.
Yvonne and Mike Hogan, New Zealand, 8/5/2023
Enjoying coffee in Tel Aviv to celebrate a successful CAR-T therapy 2019.
History of CAR-T therapy
In 1987, Israeli scientist Zelig Eshhar, PhD, developed a novel type of engineered receptor called a "chimeric antigen receptor" (CAR), designed to treat cancer. This receptor is created by inserting DNA that encodes the CAR into T cells, enabling them to target and destroy cancer cells. The first clinical trial of CAR-T therapy took place in 2012 in the United States, with a young girl named Emily Whitehead as the recipient. Since that time, the FDA has approved six different CAR-T treatments for use in various types of cancer. As of 2023, Emily is doing well and has not experienced a recurrence of the disease.
Initiating your CAR-T medical inquiry >
CAR-T testimonials >
CAR-T cell therapy in Sheba hospital in Israel >
CAR-T cell therapy in Hadassah hospital in Israel >
